Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Jul 14;301(6743):73–74. doi: 10.1136/bmj.301.6743.73

Leukaemia and cancer chemotherapy.

C J Williams 1
PMCID: PMC1663448  PMID: 2202449

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. L., Bagby G. C., Jr, Richert-Boe K., Magenis R. E., Koler R. D. Therapy-related preleukemic syndrome. Cancer. 1981 Apr 1;47(7):1867–1871. doi: 10.1002/1097-0142(19810401)47:7<1867::aid-cncr2820470725>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. L., Bagby G. C., Jr The prognostic value of chromosome studies in patients with the preleukemic syndrome (hemopoietic dysplasia). Leuk Res. 1982;6(2):175–181. doi: 10.1016/0145-2126(82)90023-6. [DOI] [PubMed] [Google Scholar]
  3. Chambers S. K., Chopyk R. L., Chambers J. T., Schwartz P. E., Duffy T. P. Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer. Cancer. 1989 Dec 15;64(12):2459–2461. doi: 10.1002/1097-0142(19891215)64:12<2459::aid-cncr2820641210>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  4. Coleman C. N., Williams C. J., Flint A., Glatstein E. J., Rosenberg S. A., Kaplan H. S. Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med. 1977 Dec 8;297(23):1249–1252. doi: 10.1056/NEJM197712082972303. [DOI] [PubMed] [Google Scholar]
  5. DeVita V. T., Jr The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture. Cancer. 1981 Jan 1;47(1):1–13. doi: 10.1002/1097-0142(19810101)47:1<1::aid-cncr2820470102>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  6. Glicksman A. S., Pajak T. F., Gottlieb A., Nissen N., Stutzman L., Cooper M. R. Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study. Cancer Treat Rep. 1982 Apr;66(4):1035–1044. [PubMed] [Google Scholar]
  7. Kaldor J. M., Day N. E., Clarke E. A., Van Leeuwen F. E., Henry-Amar M., Fiorentino M. V., Bell J., Pedersen D., Band P., Assouline D. Leukemia following Hodgkin's disease. N Engl J Med. 1990 Jan 4;322(1):7–13. doi: 10.1056/NEJM199001043220102. [DOI] [PubMed] [Google Scholar]
  8. Le Beau M. M., Albain K. S., Larson R. A., Vardiman J. W., Davis E. M., Blough R. R., Golomb H. M., Rowley J. D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar;4(3):325–345. doi: 10.1200/JCO.1986.4.3.325. [DOI] [PubMed] [Google Scholar]
  9. Pedersen-Bjergaard J., Larsen S. O. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. N Engl J Med. 1982 Oct 14;307(16):965–971. doi: 10.1056/NEJM198210143071601. [DOI] [PubMed] [Google Scholar]
  10. Tucker M. A., Coleman C. N., Cox R. S., Varghese A., Rosenberg S. A. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988 Jan 14;318(2):76–81. doi: 10.1056/NEJM198801143180203. [DOI] [PubMed] [Google Scholar]
  11. Valagussa P., Santoro A., Fossati Bellani F., Franchi F., Banfi A., Bonadonna G. Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. Blood. 1982 Mar;59(3):488–494. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES